Diagnosis: Clinical Trials

2 trials for Diagnosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Diagnosis: new trials by email Literature Review of Diagnosis trials Research Report on Diagnosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine-ketamine Combination Versus Fentanyl-midazolam During Bronchoscopy
Dexmedetomidine, Ketamine, Midazolam - Lung Diseases, Diagnosis
Phase 3CompletedUniversity of Patras502019-09-012023-12-29
Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients
Autologous transplantation - Multiple Myeloma, Diagnosis
Phase 3CompletedAzienda Ospedaliera San Giovanni Battista2982002-02-012009-08-03

Narrower conditions

Disease (2)  ·  Lung Diseases (1)  ·  Multiple Myeloma (1)  ·  Neoplasms, Plasma Cell (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Paraproteinemias (1)  ·  Respiratory Tract Diseases (1)

Interventions

Dexmedetomidine (1)  ·  Fentanyl (1)  ·  Ketamine (1)  ·  Midazolam (1)  ·  Transplantation, Autologous (1)

Sponsors

Azienda Ospedaliera San Giovanni Battista (1)  ·  University of Patras (1)

Countries

Greece (1)

Top investigators

Mario Boccadoro, MD (1)  ·  Sotirios Fouzas, MD, PhD (1)

Results publications

PMID 19965659